Results 1 to 10 of about 3,021 (181)

Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States [PDF]

Drug and Alcohol Dependence Reports, 2023
Research objective: Medication opioid use disorder (MOUD) treatment is the first-line approach to the treatment of opioid use disorder (OUD). This analysis seeks to identify “critical access” MOUD facilities that ensure geographic access for MOUD ...
Harold A. Pollack, Francis Lee, Susan Paykin, Javier Andres Rojas Aguilera   +3 more
doaj   +6 more sources

Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment program [PDF]

Substance Abuse Treatment, Prevention, and Policy, 2023
Background Medication for opioid use disorder (MOUD) is the gold standard treatment for opioid use disorder. Traditionally, “success” in MOUD treatment is measured in terms of program retention, adherence to MOUD, and abstinence from opioid and other ...
Megan K. Reed, Kelsey R. Smith, Francesca Ciocco, Richard W. Hass, Avery Lin Cox, Erin L. Kelly, Lara C. Weinstein   +6 more
doaj   +8 more sources

Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model [PDF]

Implementation Research and Practice, 2023
Background Access to providers and programs that provide medications for opioid use disorder (MOUD) remains a systemic barrier for patients with opioid use disorder (OUD), particularly if they live in rural areas.
Renee M. Cloutier, Evan S. Cole, Brianna L. McDonough, Daniel A. Lomauro, John P. Miller, Abigail L. Talbert, Todd M. Bear, Nora C. Bridges, Abigail L. Foulds, Rachel Taber, Adam J. Gordon, Gerald T. Cochran, Julie Kmiec, Julie M. Donohue, David Kelley, Ellen DiDomenico, Dale Adair, Janice L. Pringle   +17 more
doaj   +5 more sources

Factors contributing to the expansion of medication for opioid use disorder (MOUD) within the New Hampshire Department of Corrections (NHDOC) [PDF]

Health & Justice
Introduction Expanding access to medication for opioid use disorder (MOUD) to people involved in the carceral system is a priority for the New Hampshire Department of Corrections (NHDOC), where more than 40% of residents have an opioid use disorder (OUD).
Nancy Clayman, Pracha Eamranond, Helen Hanks, Michael Mitcheff, Lisa RappaMannion, Diane York, Paula Mattis, Heidi Guinen, Alex Carp, Laura Olson, Kathleen Bell, Lydia Shahi, Elizabeth Saunders, Joshua Lee, Lisa Marsch   +14 more
doaj   +6 more sources

Assessing Loneliness among Adults Receiving Outpatient Treatment with Medication for Opioid Use Disorder (MOUD). [PDF]

Int J Environ Res Public Health, 2022
Loneliness is a significant risk factor for substance use, however, impacts of treatments on loneliness are relatively unexplored. Living in a rural location is a greater risk factor for loneliness. This study examined data from a quasi-experimental study in rural Appalachia, comparing the effectiveness of Mindfulness-Based Relapse Prevention (MBRP ...
Mills R, Zullig KJ, Theeke LA, Lander LR, Hobbs GR, Herczyk J, Davis SM.   +6 more
europepmc   +5 more sources

The fentanyl made me feel like I needed more methadone”: changes in the role and use of medication for opioid use disorder (MOUD) due to fentanyl [PDF]

Harm Reduction Journal
Background Fentanyl and fentanyl analogues have disrupted the illicit drug supply through contamination of other substances (i.e., methamphetamine and cocaine) and replacement of heroin in illicit markets.
Maria Bolshakova, Kelsey A. Simpson, Siddhi S. Ganesh, Jesse L. Goldshear, Cheyenne J. Page, Ricky N. Bluthenthal   +5 more
doaj   +4 more sources

Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers. [PDF]

J Addict Med
Objectives As carceral settings increasingly offer medications for opioid use disorders (MOUD), community-based providers will need to navigate relationships with correctional agencies to ensure continuity of MOUD upon release.
Pivovarova E, Planas Garcia BY, Friedmann PD, Stopka TJ, Santelices C, Evans EA.   +5 more
europepmc   +6 more sources

Assessing Colorado’s Medication for Opioid Use Disorder (MOUD) Treatment Landscape, 2017-2021 [PDF]

Ann Fam Med, 2023
Emma Gilchrist
europepmc   +4 more sources

Primary Care Addiction Consultation Service: Colorado’s Implementation Support for Medication for Opioid Use Disorder (MOUD) [PDF]

Ann Fam Med
Tristen Hall, William Calawerts, Jacob Weiss, Kathy Cebuhar, Lauren Quintana, Chelsea Sobczak, Kimberly Wiggins   +6 more
europepmc   +4 more sources

Personally-tailored opioid-overdose and medication for opioid use disorder (MOUD) education (TOME) significantly increases MOUD and overdose knowledge in peripartum individuals: Results from a randomized controlled pilot trial. [PDF]

Drug Alcohol Depend
Winhusen TJ, Kropp F, Smid MC, Young JL, Davies TH, Lewis D, Rosa C, Dilawar M, Krans EE, Hodgkins C, Cochran G, Lofwall MR.   +11 more
europepmc   +4 more sources